The Beauty Health Company (SKIN) CEO Andrew Stanleick on Q2 2022 Results - Earnings Call Transcript

Aug. 09, 2022 6:45 PM ETThe Beauty Health Company (SKIN), SKINW
SA Transcripts profile picture
SA Transcripts

The Beauty Health Company (NASDAQ:SKIN) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET

Company Participants

Eduardo Rodriguez - Senior Director of M&A and Investor Relations

Andrew Stanleick - President & Chief Executive Officer

Liyuan Woo - Chief Financial Officer

Conference Call Participants

Maggie Boeye - William Blair

Steph Wissink - Jefferies

Oliver Chen - Cowen and Company

Olivia Tong - Raymond James

Korinne Wolfmeyer - Piper Sandler

Jon Block - Stifel

Allen Gong - JPMorgan

Bruce Jackson - The Benchmark Company

Kyle Rose - Canaccord Genuity

Linda Bolton-Weiser - D.A. Davidson

Amit Hazan - Goldman Sachs


Good morning, and welcome to Beauty Health Corp.'s 2022 Earnings Call. [Operator Instructions] Please note that this event is being recorded.

I’d like to turn the call over to Mr. Eduardo Rodriguez, Senior Director of M&A and Investor Relations. Please go ahead, sir.

Eduardo Rodriguez

Thank you, operator, and good morning, everyone. Thank you for joining The Beauty Health Company's conference call to discuss the company's second quarter 2022 financial results, which were released this morning and can be found on our website at Also available on our website is an investor presentation that will be referenced during this call. With me on the call today are Beauty Health's President and Chief Executive Officer, Andrew Stanleick; and Chief Financial Officer, Liyuan Woo.

Before we get started, I would like to remind you of the company's safe harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC. This call will contain non-GAAP financial measures, such as adjusted gross margin and adjusted EBITDA. Reconciliation of these non-GAAP measures to the most comparable GAAP

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.